Treatment of Melasma with Cysteamine cream compared to Hydroquinone cream

Phase 3

• Conditions: Melasma; Skin - Dermatological conditions

• Registration Number: ACTRN12619000406101
• Lead Sponsor: Dr Michelle Rodrigues

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-13
• Study Completion: 2020-03-07
• Last Update Posted: 16 February 2021

Recruitment & Eligibility

• Status: Stopped early
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

1.Must provide informed consent
2.Must be over the age of 18 and female
3.Moderate to severe melasma defined by the following at screening visit:
a.Modified MASI scoring
4.Melasma present for at least 3 months
5.Willing and able to comply with study instructions and return to the study site for required visits
6.Must be able to comply with the study regimen for the duration of the study.

Exclusion Criteria

1.Pregnant or breastfeeding
2.Rashes on the face
3.Job which is primarily outdoors (more than 2 hours per day) or goes to tanning salons
4.Hydroquinone, or other bleaching agents, used within the last month
5.Topical steroid applied to the face within the last month
6.Retin A, retinol, tretinoin, Differin, or adapalene used within the last month
7.Laser treatment to the face within the last month

Study & Design

• Study Type: Interventional
• Study Design: Not specified